Ren J. H., Hu J. L., Cheng S. T., Yu H. B., Wong V. K. W., Law B. Y. K., Yang Y. F., Huang Y., Liu Y., Chen W. X., Cai X. F., Tang H., Hu Y., Zhang W. L., Liu X., Long Q. X., Zhou L., Tao N. N., Zhou H. Z., Yang Q. X., Ren F., He L., Gong R., Huang A. L.（黄爱龙）, Chen J.（陈娟） (2018) SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases. Hepatology 68: 1260-1276.（IF: 13.246）

Zhao L., Zhang C., Luo X., Wang P., Zhou W., Zhong S., Xie Y., Jiang Y., Yang P., Tang R., Pan Q., Hall A. R., Luong T. V., Fan J., Varghese Z., Moorhead J. F., Pinzani M., Chen Y.（陈压西）, Ruan X. Z.（阮雄中） (2018) CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol 69: 705-717.（IF: 14.911）

Qiu K., Liu B., Li S. Y., Li H., Chen Z. W., Luo A. R., Peng M. L., Ren H., Hu P.（胡鹏） (2018) Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance. Aliment Pharmacol Ther 47: 1340-1348.（IF: 7.286）

Yang P., Su C., Luo X., Zeng H., Zhao L., Wei L., Zhang X., Varghese Z., Moorhead J. F., Chen Y.（陈压西） Ruan X. Z. （阮雄中）(2018) Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway. Cancer Lett 438: 76-85.（IF: 6.375）

Chen X., Hu Y., Zhang W., Chen K., Hu J., Li X., Liang L., Cai X., Hu J., Wang K.（汪凯）, Huang A.（黄爱龙）, Tang N.（唐霓） (2018) Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway. Free Radic Biol Med 131: 225-236.（IF: 5.606）

Yan S., Tang Z., Chen K., Liu Y., Yu G., Chen Q., Dang H., Chen F., Ling J., Zhu L., Huang A.（黄爱龙）, Tang H.（汤华） (2018) Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J Exp Clin Cancer Res 37: 214.（IF: 5.189）

Zhu L., Liu Y., Chen Q., Yu G., Chen J., Chen K., Yang N., Zeng T., Yan S., Huang A.（黄爱龙）, Tang H.（汤华） (2018) Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma. Cell Physiol Biochem 50: 2229-2248.（IF: 5.104）

Cui J., Zhang W.（*）, Huang E., Wang J., Liao J., Li R., Yu X., Zhao C., Zeng Z., Shu Y., Zhang R., Yan S., Lei J., Yang C., Wu K., Wu Y., Huang S., Ji X., Li A., Gong C., Yuan C., Zhang L., Liu W., Huang B., Feng Y., An L., Zhang B., Dai Z., Shen Y., Luo W., Wang X., Huang A., Luu H. H., Reid R. R., Wolf J. M., Thinakaran G., Lee M. J., He T. C.（*） (2019) BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells. Lab Invest 99: 58-71.（IF:4.857）（我院为第一完成单位）

Luo Q., Yan L., Xu P., Xiong C., Yang Z., Hu P., Hu H., Hong R.（任红） (2018) Discovery of a polysaccharide from the fruiting bodies of Lepista sordida as potent inhibitors of indoleamine 2, 3-dioxygenase (IDO) in HepG2 cells via blocking of STAT1-mediated JAK-PKC-delta signaling pathways. Carbohydr Polym 197: 540-547.（IF: 4.811）

Chen Y., Hu J., Cai X., Huang Y., Zhou X., Tu Z., Hu J., Tavis J. E., Tang N., Huang A.（黄爱龙）, Hu Y.（胡源） (2018) APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antiviral Res 149: 16-25.（IF: 4.271）

Li X., Pan E., Zhu J., Xu L., Chen X., Li J., Liang L., Hu Y., Xia J., Chen J., Chen W., Hu J., Wang K., Tang N.（唐霓）, Huang A.（黄爱龙） (2018) Cisplatin Enhances Hepatitis B Virus Replication and PGC-1alpha Expression through Endoplasmic Reticulum Stress. Sci Rep 8: 3496.（IF: 4.259）

Zhou H., Cai Y., Liu D., Li M., Sha Y., Zhang W., Wang K., Gong J., Tang N., Huang A.（黄爱龙）, Xia J.（*） (2018) Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21(Waf1/Cip1) and p19(INK4d) upregulation in hepatocellular carcinoma. Cell Prolif 51: e12447.（IF: 4.112）

Li H., Zhang L., Ren H., Hu P.（胡鹏） (2018) Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B. Infect Drug Resist 11: 671-680.（IF: 3.779）

Hu J., Qiao M., Chen Y., Tang H., Zhang W., Tang D., Pi S., Dai J., Tang N., Huang A., Hu Y.（胡源） (2018) Cyclin E2-CDK2 mediates SAMHD1 phosphorylation to abrogate its restriction of HBV replication in hepatoma cells. FEBS Lett 592: 1893-1904.（IF: 3.623）

Zeng T., Wang D., Chen J., Chen K., Yu G., Chen Q., Liu Y., Yan S., Zhu L., Zhou H., Huang A.（黄爱龙）, Tang H.（汤华） (2018) AF119895 regulates NXF3 expression to promote migration and invasion of hepatocellular carcinoma through an interaction with miR-6508-3p. Exp Cell Res 363: 129-139.（IF: 3.546）

Zhang L., Li H., Ren H., Hu P.（胡鹏） (2018) Circulating PD-1(hi)CXCR5(+)CD4(+) T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-alpha therapy. Mol Immunol 103: 270-278.（IF: 3.236）

Lin Q., Peng S., Yang Y.（杨轶轩） (2018) Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H. Int J Oncol 53: 266-274.（IF: 3.079）

Zhao L., Varghese Z., Moorhead J. F., Chen Y., Ruan X. Z.（阮雄中） (2018) CD36 and lipid metabolism in the evolution of atherosclerosis. Br Med Bull 126: 101-112.（IF: 3.045）

Huang C., Yang X. H., Yang Y. L., Huang A. L., Shi X. F. （石小枫）(2018) Clinical-features analysis on 926 patients with virological breakthrough in chronic hepatitis B receiving nucleos(t)ide analogues. Eur J Intern Med 53: e9-e10.（IF: 2.96）

Liu N., Liu B., Zhang L., Li H., Chen Z., Luo A., Chen M., Peng M., Yin W., Ren H., Hu P.（胡鹏） (2018) Recovery of circulating CD56(dim) NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg. Int Immunopharmacol 62: 59-66.（IF: 2.956）

Cheng F., Chen Y., Zhan Z., Liu Y., Hu P., Ren H., Tang H., Peng M.（彭明利） (2018) Curc-mPEG454, a PEGylated Curcumin Derivative, Improves Anti-inflammatory and Antioxidant Activities: a Comparative Study. Inflammation 41: 579-594.（IF: 2.955）

Chang Y., Li H., Ren H., Xu H., Hu P.（胡鹏） (2018) Misclassification of chronic hepatitis B natural history phase: Insight from new ALT, AST, AKP, and GGT reference intervals in Chinese children. Clin Chim Acta 489: 61-67.（IF: 2.873）

Tao N. N., Gong R., Chen X., He L., Ren F., Yu H. B., Chen J., Ren J. H.（*） (2018) Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4alpha. J Gen Virol 99: 645-654.（IF: 2.838）（我院为第一完成单位）

Wang X., Deng W., Qian K., Deng H., Huang Y., Tu Z., Huang A.（黄爱龙）, Long Q.（龙泉鑫） (2018) Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants. Eur J Clin Microbiol Infect Dis 37: 1153-1162.（IF: 2.727）

Zhou X., Gao H., Guo Y., Chen Y.（陈压西）, Ruan X. Z. （阮雄中）(2018) Knocking down Stard3 decreases adipogenesis with decreased mitochondrial ROS in 3T3-L1 cells. Biochem Biophys Res Commun 504: 387-392.（IF: 2.466）

Yu H. B., Jiang H., Cheng S. T., Hu Z. W., Ren J. H.（*）, Chen J.（陈娟） (2018) AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo. Int J Med Sci 15: 1356-1364.（IF: 2.399）

Cheng S. T., Yuan D., Liu Y., Huang Y., Chen X., Yu H. B., He L., Jiang H., Ren J. H., Chen J.（陈娟） (2018) Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection. Int J Med Sci 15: 188-194.（IF: 2.399）

Feng L.（奉镭）, Deng C., Li Y. (2018) Assessment of the Relationship between Carotid Intima-Media Thickening and Early-Stage Diabetic Kidney Disease Coupled with Helicobacter pylori Infection. Dis Markers 2018: 3793768.（IF: 2.348）

Luo A., Jiang X., Ren H.（任红） (2018) Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis. Virol J 15: 139.（IF: 2.139）

Liu J., Yang P., Zuo G.（*）, He S., Tan W., Zhang X., Su C., Zhao L., Wei L., Chen Y., Ruan X., Chen Y.（陈压西） (2018) Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Lipids Health Dis 17: 153.（IF: 2.073）

Luo A., Jiang X., Ren H. （任红）(2018) Entecavir-based combination therapies for chronic hepatitis B: A meta-analysis. Medicine (Baltimore) 97: e13596.（IF: 1.803）

Chen J. Y., Gan C. Y., Cai X. F., Zhang W. L., Long Q. X., Wei X. F., Hu Y., Tang N., Chen J., Guo H., Huang A. L.（黄爱龙）, Hu J. L.（胡接力） (2018) Fluorescent protein tagged hepatitis B virus capsid protein with long glycine-serine linker that supports nucleocapsid formation. J Virol Methods 255: 52-59.（IF: 1.693）